If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMJGleeson Regulatory News (GLE)

Share Price Information for MJGleeson (GLE)

Share Price is delayed by 15 minutes
Get Live Data
235.00    -5.00 (-2.08%)
Bid:
235.00
Ask:
236.00
Spread: 1.00 (0.426%)
Market Cap: £137.09m
GLE Live PriceLast checked at - London Stock Exchange

Intraday MJGleeson Share Chart

Performance Share Plan award to Directors/PDMRs

12 Nov 2019 15:40

RNS Number : 1678T
MJ Gleeson PLC
12 November 2019
Β 

12 November 2019

Β 

MJ Gleeson plc ("Gleeson" or the "Company")

Β 

Performance Share Plan award to Directors/PDMRs

Β 

The Company announces that on 11 November 2019 Stefan Allanson, Chief Financial Officer, exercised share options ("Share Options") over 73,531 ordinary shares of 2 pence each in the capital of the Company ("Ordinary Shares") in connection with the Company's Long Term Incentive Plan ("LTIP").

Β 

Application has been made for the admission to trading of the new Ordinary Shares, which rank pari passu in all respects with the Company's existing Ordinary Shares, on the Main Market of the London Stock Exchange and to listing on the Official List of the UKLA, with dealings expected to commence on or around 15 November 2019.

Β 

Subsequent to the exercise and issue of the new Ordinary Shares, the Company has been notified that Stefan Allanson sold 34,663 Ordinary Shares at a price of Β£8.00 per Ordinary Share in order to satisfy tax liabilities resulting from the exercise of the above-mentioned options. Following the exercise and the sale, Stefan Allanson's shareholding has increased to 55,765 Ordinary Shares in the Company, representing 0.1 per cent. of the total voting rights in the Company.

Β 

Total Voting Rights

Following the issue of the new Ordinary Shares the total number of issued Ordinary Shares is 54,675,284. The Company does not hold any Ordinary Shares in Treasury.

Β 

Therefore, the total number of Ordinary Shares with voting rights is 54,675,284 which may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FCA's DTR.

Β 

Enquiries:

MJ Gleeson plc Tel: 44 1142 612 900

James Thomson Interim Chief Executive Officer

Stefan Allanson Chief Financial Officer

Β 

Instinctif Partners Tel: 44 20 7457 2020

Mark Garraway

James Gray

Β 

N+1 Singer Tel: 44 20 7496 3000

Shaun Dobson

Rachel Hayes

Β 

Liberum Tel: 44 20 3100 2222

Neil Patel

Richard Bootle

Β 

The following notifications are intended to satisfy the Company's obligations under Article 19(3) of EU Regulation No 596/2014 (the Market Abuse Regulation).

1

Β 

Details of the person discharging managerial responsibilities / person closely associated

Β 

a)

Β 

Name

Β 

Β 

Stefan Allanson

2

Β 

Reason for the notification

Β 

a)

Β 

Position/status

Β 

Chief Financial Officer

b)

Β 

Initial notification /Amendment

Β 

Β 

Initial Notification

3

Β 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Β 

a)

Β 

Name

Β 

MJ Gleeson plc

b)

Β 

LEI

Β 

21380064K7N2W7FD6434

4

Β 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Β 

a)

Β 

Description of the financial instrument, type of instrument

Β 

Identification code

Β 

Β 

Ordinary shares of 2 pence each

Β 

Β 

GB00BRKD9Z53

b)

Β 

Nature of the transaction

Β 

Β 

Exercise of Share Options

Β 

c)

Β 

Price(s) and volume(s)

Β 

Β 

Β 

Price(s)

Β 

Volume(s)

Nil (exercise of options)

73,531

Β 

Β 

d)

Β 

Aggregated information

Β 

- Aggregated volume

Β 

Β 

- Price

Β 

Β 

Β 

n/a

e)

Β 

Date of the transaction

Β 

Β 

11 November 2019

f)

Β 

Place of the transaction

Β 

Β 

Off market

4

Β 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Β 

a)

Β 

Description of the financial instrument, type of instrument

Β 

Identification code

Β 

Β 

Ordinary shares of 2 pence each

Β 

Β 

GB00BRKD9Z53

b)

Β 

Nature of the transaction

Β 

Β 

Sale of Ordinary Shares

Β 

c)

Β 

Price(s) and volume(s)

Β 

Β 

Β 

Price(s)

Β 

Volume(s)

800p

34,663

Β 

Β 

d)

Β 

Aggregated information

Β 

- Aggregated volume

Β 

Β 

- Price

Β 

Β 

Β 

n/a

e)

Β 

Date of the transaction

Β 

Β 

11 November 2019

f)

Β 

Place of the transaction

Β 

Β 

London Stock Exchange (XLON)

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
Β 
END
Β 
Β 
DSHCKBDNPBDDODD
Date   Source Headline
28th Feb 20177:00 amRNSTotal Voting Rights
27th Feb 20177:00 amRNSHalf-year Report
10th Feb 20179:00 amRNSDirector/PDMR Shareholding
31st Jan 20177:00 amRNSTotal Voting Rights
9th Jan 20177:00 amRNSNotice of Results and Trading Update
6th Jan 20174:15 pmRNSDirector/PDMR Shareholding
30th Dec 20167:00 amRNSTotal Voting Rights
21st Dec 20164:40 pmRNSSecond Price Monitoring Extn
21st Dec 20164:35 pmRNSPrice Monitoring Extension
12th Dec 20164:58 pmRNSPerformance Share Plan Award to Directors
8th Dec 20161:30 pmRNSResult of AGM
8th Dec 20167:00 amRNSAGM Statement
7th Dec 201610:15 amRNSDirector/PDMR Shareholding
30th Nov 20167:00 amRNSTotal Voting Rights
9th Nov 201610:36 amRNSDirector/PDMR Shareholding
4th Nov 20167:00 amRNSNotice of AGM
31st Oct 20167:00 amRNSTotal Voting Rights
6th Oct 20164:13 pmRNSDirector/PDMR Shareholding
30th Sep 20167:00 amRNSTotal Voting Rights
29th Sep 20163:45 pmRNSHolding(s) in Company
29th Sep 201611:59 amRNSDirector/PDMR Shareholding
26th Sep 20167:00 amRNSFinal Results
6th Sep 20161:27 pmRNSDirector/PDMR Shareholding
31st Aug 20167:00 amRNSTotal Voting Rights
9th Aug 201611:32 amRNSDirector/PDMR Shareholding
29th Jul 20167:00 amRNSTotal Voting Rights
7th Jul 201610:37 amRNSDirector/PDMR Shareholding
5th Jul 20167:00 amRNSTrading Update
30th Jun 20166:26 pmRNSDirector/PDMR Shareholding
30th Jun 20167:00 amRNSTotal Voting Rights
29th Jun 20161:02 pmRNSDirector/PDMR Shareholding
28th Jun 20164:35 pmRNSPrice Monitoring Extension
28th Jun 201612:34 pmRNSDirector/PDMR Shareholding
27th Jun 20165:52 pmRNSDirector/PDMR Shareholding
24th Jun 20164:35 pmRNSPrice Monitoring Extension
9th Jun 20166:08 pmRNSDirector/PDMR Shareholding
31st May 20167:00 amRNSTotal Voting Rights
20th May 20167:00 amRNSNotice of Site Visit
29th Apr 20167:00 amRNSTotal Voting Rights
21st Apr 20167:00 amRNSAppointment of Joint Broker
18th Apr 201610:56 amRNSDirector/PDMR Shareholding
15th Apr 20169:59 amRNSDirector/PDMR Shareholding
7th Apr 20169:50 amRNSDirector/PDMR Shareholding
7th Apr 20169:42 amRNSDirector/PDMR Shareholding
31st Mar 20167:00 amRNSTotal Voting Rights
15th Mar 20169:03 amRNSNotification of Transaction by Director
9th Mar 20165:17 pmRNSDirector/PDMR Shareholding
29th Feb 20167:00 amRNSTotal Voting Rights
22nd Feb 20167:00 amRNSHalf Yearly Report
8th Feb 20163:39 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.